GlassScriptPhysician profile
Alison B Smoller
NPI 1730384884
$2,338.32
in general payments reported to CMS, 2019-2025
15 companies · $44.61 in 2025
The $44.61 reported for 2025 was less than what a typical Developmental - Behavioral Pediatrics provider received nationally (typical 2025 total: $79.84).
See the full distribution for Developmental - Behavioral Pediatrics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $220 · 2021: $490 · 2022: $929 · 2023: $292 · 2024: $148 · 2025: $44.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $646.88 | 2019-2024 | Adzenys Xr-Odt |
| Supernus Pharmaceuticals, INC. | $624.59 | 2021-2025 | Qelbree |
| Corium, LLC | $535.13 | 2022-2025 | Azstarys |
| Tris Pharma INC | $215.60 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.34 | 2019 | |
| Ironshore Pharmaceuticals INC. | $54.35 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.30 | 2019-2021 | |
| Adlon Therapeutics L.P. | $36.28 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $29.66 | 2024 | Uzedy |
| Otsuka America Pharmaceutical, INC. | $27.75 | 2023 | Rexulti |
| Rhodes Pharmaceuticals L.P. | $14.82 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.39 | 2024 | Relexxii |
| Vanda Pharmaceuticals INC. | $14.26 | 2023 | Fanapt, Hetlioz |
| Merck Sharp & Dohme LLC | $13.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Smoller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.